Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupDermatologic OncologyradiotherapyDiseaseSquamous Cell Carcinoma of the SkinSubgroupICD10C44.9MeSHCarcinoma, Squamous CellSequenceCETU400/Radiation, CSCC, C1 (PID2163) -|- CETU250/Radiation, C2+ (PID2164)ChemotherapyChemo-substanceCarboplatinCetuximabCisplatinChemo-substanceCarboplatinCetuximabCisplatinChemo-substanceCarboplatinCetuximabCisplatinChemo-substanceCarboplatinCetuximabCisplatinNo. Substances1 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDexamethasoneDimetindenFosaprepitantGranisetronHydrocortisoneMagnesium sulfateMinocyclinePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneDimetindenFosaprepitantGranisetronHydrocortisoneMagnesium sulfateMinocyclinePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneDimetindenFosaprepitantGranisetronHydrocortisoneMagnesium sulfateMinocyclinePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneDimetindenFosaprepitantGranisetronHydrocortisoneMagnesium sulfateMinocyclinePotassium chlorideNo. Substances356Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationTherapy phaseTherapy intentioncurativeRisksAnemia Hb below 8g/dlCardiotoxicityConstipationDehydrationDiarrheaDysphagiaEmetogenicity (MASCC/ESMO)Febrile NeutropeniaHyperbilirubinemiaHypomagnesemiaIncrease AminotransferasesInfectionsMucositisNeuropathyNeutropeniaRashRenal FailureThrombocytopenia below 50 000/µl only studiesPublicationAuthorJoseph KNottage MKDiseasePlattenepithelkarzinom der Haut, lokal fortgeschritten, nicht operabel, ECOG 0-2Plattenepithelkarzinom der Haut, lokal fortgeschritten oder Lymphknotenmetastasen, nicht operabel, ECOG 0-2OriginCancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland, AustraliaUniversity of Alberta and Cross Cancer Institute, Edmonton, Alberta, CanadaProtocols in Revision 4 protocols foundProtocols under revision.Carboplatin 2 / Radiation, Squamous Cell Carcinoma of the Skin (PID2178 V1.0)Cetuximab 250 / Radiation, Squamous Cell Carcinoma of the Skin, Cycle 2+ (PID2164 V1.0)Cetuximab 400 / Radiation, Squamous Cell Carcinoma of the Skin, Cycle 1 (PID2163 V1.0)Cisplatin 40 / Radiation, Squamous Cell Carcinoma of the Skin (PID2162 V1.0)
